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ABSTRACT

Introduction: Acute generalized exanthematous pustulosis (AGEP) is a rare adverse effect of
clindamycin characterized by widespread papules and pustulosis 1 – 3 weeks of its use.
Case description: We present a case of a 71-year-old woman diagnosed with AGEP after
clindamycin use for a tooth infection. She had been started on empiric prednisone without
benefit. She did not have any systemic involvement and had an unremarkable blood work .
Her rash resolved completely in a month.

1. Clinical description
The patient is a 71-year-old lady seen in primary
care physician’s office for non-improvement of
diffuse rash that started 2 days prior to completing
a 10-day course of clindamycin for a tooth infection. Her rash had been present for 10 days on
presentation. She noted erythematous papules and
pustules that started on her neck and then quickly
spread to her chest and arms over 2 days. They
were slightly itchy. She had gone to an urgent care
where she was prescribed an 8-day course of prednisone taper. On questioning, she mentioned that
she had noted clearing of the rash from the neck
region where it had first appeared. She had not
noted any mucosal involvement. She did not have
any fever or chills. She denied shortness of breath,
wheezing or chest tightness. Her past medical history was significant for hypertension and hyperlipidemia. She did not have a known history of
psoriasis or any other skin condition. Her home
medications included hydrochlorothiazide 12.5 mg
daily, meloxicam 15 mg daily, omeprazole 20 mg
daily, simvastatin 20 mg nightly, and alprazolam
0.25 mg p.r.n. nightly. None of her home medications were new or had been recently changed and
were continued during prednisone use. On examination, her temperature was 98.2 ºF, pulse 96 beats
per minute, blood pressure 137/78 mm Hg, and
respiratory rate 12 breaths per minute. The patient
had a generalized papular rash that coalesced to
form plaques on her arms and was studded with
non-follicular pustules, along with skin desquamation (Figure 1). Superimposed bacterial skin infection was not noted. She did not have any cervical,
axillary or inguinal lymphadenopathy. System
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examination was unremarkable. Given history of
recent clindamycin use and presentation, acute
generalized exanthematous pustulosis (AGEP) was
suspected. The patient was reassured about the
benign nature of the illness and recommended to
complete the prednisone taper. She was advised to
use fexofenadine as needed for itching. Her complete blood count was within normal range except
for an elevated white count of 13.7 10E3/µL (reference range: 4.8–10.8 10E3/µL) with 76.2% (reference range: 37–75%) neutrophils related to
prednisone use. Her liver function test was unremarkable. Skin biopsy was not done as it was most
likely thought to be related to recent clindamycin
use. The patient noted complete resolution of rash
in a month on follow up.

2. Teaching points
(1) Clindamycin-associated AGEP should in suspected in patients presenting with erythema
followed by papules and pustules within 1
−3 weeks of clindamycin use [1,2].
(2) AGEP is self-limited and treatment involves
discontinuation of clindamycin and supportive
therapy with corticosteroids, antihistamines or
antibiotics [2].

Multiple Choice Question
A 60-year-old man presents to your clinic for a rash that
started 1 week after completing a 7-day course of clindamycin for cellulitis. On examination, the patient has generalized erythematous papules and non-follicular pustules
involving his face, hands, and trunk. Patient denies fever or
chills. His complete blood count and liver function test are
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unremarkable. Which of the following is the most likely
diagnosis?
A. Contact dermatitis
B. Acute generalized exanthematous pustulosis
C. Fixed drug eruption
D. Drug reaction with eosinophilia and systemic symptoms
Answer B: Acute generalized exanthematous pustulosis
The patient has a history of recent antibiotic use and
diffuse rash comprising of papules and non-follicular pustules
typical for acute generalized exanthematous pustulosis.
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Figure 1. Patient’s right arm demonstrating generalized
papular rash, pustules along with skin desquamation.
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